Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)

被引：24

作者：

Asano, Yasutomi ^{[1
]}

Kitamura, Shuji ^{[1
]}

Ohra, Taiichi ^{[1
]}

Aso, Kazuyoshi ^{[1
]}

Igata, Hideki ^{[3
]}

Tamura, Tomoko ^{[3
]}

Kawamoto, Tomohiro ^{[2
]}

Tanaka, Toshimasa ^{[2
]}

Sogabe, Satoshi ^{[2
]}

Matsumoto, Shin-ichi ^{[2
]}

Yamaguchi, Masashi ^{[2
]}

Kimura, Hiroyuki ^{[2
]}

Itoh, Fumio ^{[1
]}

机构：

[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Med Chem Res Labs, Yodogawa Ku, Osaka 5328686, Japan

[2] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Discovery Res Ctr, Yodogawa Ku, Osaka 5328686, Japan

[3] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Pharmacol Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2008年 / 16卷 / 08期

关键词：

JNK; JNK inhibitor; isoquinolone; SAR; Modeling; heart failure; cardiac hypertrophy; X-ray crystallography;

D O I：

10.1016/j.bmc.2008.02.027

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modi. cation at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：4715 / 4732

页数：18

共 50 条

[1] Discovery, Synthesis, and Biological Evaluation of a Novel Group of Selective Inhibitors of Filoviral Entry
Yermolina, Maria V.
Wang, Jizhen
Caffrey, Michael
Rong, Lijun L.
Wardrop, Duncan J.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (03) : 765 - 781
[2] Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor
Li, Qi
Xing, Shuaishuai
Chen, Ying
Liao, Qinghong
Xiong, Baichen
He, Siyu
Lu, Weixuan
Liu, Yang
Yang, Hongyu
Li, Qihang
Feng, Feng
Liu, Wenyuan
Chen, Yao
Sun, Haopeng
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 10030 - 10044
[3] Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors
Abu Rabah, Reinad R.
Sebastian, Anusha
Vunnam, Srinivasulu
Sultan, Shaista
Tarazi, Hamadeh
Anbar, Hanan S.
Shehata, Mahmoud K.
Zaraei, Seyed-Omar
Elgendy, Sara M.
Al Shamma, Salma A.
Omar, Hany A.
Al-Tel, Taleb H.
El-Gamal, Mohammed, I
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 69
[4] Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors
Chen, Lianru
Wang, Bin
Li, Hongming
Mao, Jianming
Liang, Zhiling
Chen, Ya
Yu, Mingyang
Liu, Yuxia
Liao, Zibin
Yang, Yuanqian
Wu, Xiaojing
Wang, Huazheng
Yang, Yonghong
Xiang, Ruojing
Zhang, Luyong
Li, Zheng
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 276
[5] Discovery of novel and highly selective allosteric inhibitors of PAK1
Lindvall, Mika
Karpov, Alexei
Bellamacina, Cornelia
Daniel, Dylan
Fabbro, Doriano
Fernandez, Cesar
Jacob, Sandra
Jahnke, Wolfgang
Moebitz, Henrik
Pecchi, Sabina
Pecchi, Sabina
Shoemaker, Kevin
Wang, John
Breitenstein, Werner
Gutmann, Sascha
Lagasse, Stephanie
Machajewski, Timothy
Marzinzik, Andreas
Galuba, Inga
Trappe, Joerg
Crawford, Kenneth
Voliva, Charles
Lai, Albert
Hinh, Linda
Rummel, Gabriele
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[6] Design, synthesis and biological evaluation of highly potent and selective CYP1B1 inhibitors
Zhang, Haoyu
Xu, Ping
Wang, Ting
Wang, Shiyu
Li, Weixia
Mao, Jianping
Wang, Jian
Zhang, Fengjiao
Cheng, Maosheng
[J]. NEW JOURNAL OF CHEMISTRY, 2023, 47 (12) : 5680 - 5690
[7] Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation
Duan, Ying-Chao
Guan, Yuan-Yuan
Zhai, Xiao-Yu
Ding, Li-Na
Qin, Wen-Ping
Shen, Dan-Dan
Liu, Xue-Qi
Sun, Xu-Dong
Zheng, Yi-Chao
Liu, Hong-Min
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 : 246 - 258
[8] Design, Synthesis, and Biological Evaluation of Quercetagetin Analogues as JNK1 Inhibitors
Hierold, Judith
Baek, Sohee
Rieger, Rene
Lim, Tae-Gyu
Zakpur, Saman
Arciniega, Marcelino
Lee, Ki Won
Huber, Robert
Tietze, Lutz F.
[J]. CHEMISTRY-A EUROPEAN JOURNAL, 2015, 21 (47) : 16887 - 16894
[9] Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
Nishida, Haruyuki
Hasuoka, Atsushi
Arikawa, Yasuyoshi
Kurasawa, Osamu
Hirase, Keizo
Inatomi, Nobuhiro
Hori, Yasunobu
Sato, Fumihiko
Tarui, Naoki
Imanishi, Akio
Kondo, Mitsuyo
Takagi, Terufumi
Kajino, Masahiro
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (12) : 3925 - 3938
[10] Discovery and biological evaluation of a novel, potent and selective series of ACC2 inhibitors
Gu, Yu Gui
Weitzberg, Moshe
Clark, Richard F.
Xu, Xiangdong
Li, Qun
Zhang, Tianyuan
Hansen, T. Matthew
Keyes, Robert F.
Liu, Gang
Xin, Zhili
Wang, Xiaojun
Wang, Rongqi
McNally, Teresa
Zinker, Bradley A.
Dickinson, Bob W.
Lubbers, Nathan L.
Yang, Yi
Beno, David W. A.
Widomski, Deborah L.
Waring, Jeffrey F.
Carroll, Sherry L.
Healan-Greenberg, Christine H.
Blomme, Eric A.
Frevert, Ernst U.
Beutel, Bruce A.
Sham, Hing L.
Camp, Heidi S.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 614 - 614

← 1 2 3 4 5 →